Atlas Stack (ITPP + Cardarine + SR-9009) – Product Information
The Atlas Stack, consisting of ITPP, Cardarine (GW501516), and SR-9009, is a combination of compounds that may be researched together for their potential effects on performance and endurance.
The combination of ITPP, Cardarine, and SR-9009 may collectively contribute to improved endurance by enhancing oxygen utilization, fat oxidation, and metabolic regulation. Researching their combined effects may provide insights into their potential synergy in enhancing endurance capacity.
PureRawz Sells The Atlas Stack for research purposes only.
ITTP or Myo-inositol trispyrophospate is a research compound currently being investigated in hopes of aiding patients weakened by myocardial infarctions, due to its ability to increase oxygen supply to weakened or damaged cardiac muscle. Designed to make hemoglobin increase its release of oxygen above normal levels, ITPP has the potential ability to boost exercise levels in ailing mice by up to 35% when given dissolved in water. When administered via injection into the abdomen of the mice, exercise levels saw a potential rise up to a massive 60%. Further research is warranted to investigate the potential of ITPP in oxygen transport and endurance training.
|ITPP Myo-inositol trispyrophosphate
Cardarine, also known as GW-501516, is a PPAR agonist. Cardarine is used in research for its potential to facilitate fat-burning by increasing endurance and stamina. A study done on the effects of GW-501516 for enhancing running endurance in Kunming mice demonstrated that a 3-week treatment with GW501516 increased the running performance of both trained and untrained mice. Like training, GW501516 promoted mitochondrial fatty acid oxidation and increased fat metabolism in muscle tissue. This could potentially lead to less demanding cardiovascular work, increasing weekly deficits, and resulting in increased fat loss.
A recent study on diet-induced obese mice treated with SR9009 and SR9011 (i.e., two times a day for 30 days) has been reported to display decreased fat mass and markedly improved dyslipidemia and hyperglycemia. The activation of REV-ERB leads to the enhancement of circadian rhythm observed in mice. This affects behavior, sleep cycle, and some functions related to an increment in energy production.